Skip to main content
SpringerLink
Log in

Serum N terminal procollagen III fragment: A predictive marker of joint destruction in rheumatoid arthritis?

  • Originals
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Summary

The level of the N terminal fragment of procollagen III (P3NP) levels of 100 consecutive patients affected by rheumatoid arthritis (RA) were evaluated in comparison with disease activity markers (erythrocytes sedimentation rate, C reactive protein), immunological status (rheumatoid factors, immune complexes) and joint destruction (assessed according to the Steinbrocker index). P3NP levels showed no significant relationship either to disease activity or to immunological status; however, a strong association was found between X-ray grade and P3NP values. A two-year retrospective study of 32 patients belonging to the original 100 patient population allowed us to assign a predictive value for joint destruction to the P3NP level in the early stage of the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Harris, Jr. E.D. Rheumatoid arthritis. Pathophysiology and implications for therapy. In: Mechanism of Disease. Ed: F.H. Epstein. N Engl J Med 1990, 322, 1277–1289.

  2. Sambrook, P.N., Reeve, J. Bone disease in rheumatoid arthritis. Clin Sci 1989, 74, 225–230.

    Article  Google Scholar 

  3. Steinbrocker, O., Teager, Ch., Batterman, R.C. Therapeutic criteria in rheumatoid arthritis. JAMA 1949, 140, 659–662.

    Article  CAS  Google Scholar 

  4. Mottonen, T.T., Hannonen, P., Toivonen, J., Rekonen, A., Oka, M. Value of joint scintigraphy in the prediction of erosiveness in early rheumatoid arthritis. Ann Rheum Dis 1988, 47, 183–189.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Engstrom-Laurent, A., Hallgren, R. Circulating hyaluronate in rheumatoid arthritis: relationship to inflammatory activity and the effect of corticosteroid therapy. Ann Rheum Dis 1985, 44, 83–88.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Mbuyi, J.M., Dequeker, J., Teblick, M., Merlevede, M. Relevance of urinary excretion of alcian blue-glycosaminoglycans complexes and hydroxyproline to disease activity in rheumatoid arthritis. J Rheumatol 1982, 9, 579–583.

    CAS  PubMed  Google Scholar 

  7. Horslev-Petersen, K., Bentsen, K.D. Junker, P., Lorenzen, I.B. Serum aminoterminal type III procollagen peptide in rheumatoid arthritis: relationship to disease activity, treatment, and development of joint erosions. Arthritis Rheum 1986, 29, 592–599.

    Article  CAS  PubMed  Google Scholar 

  8. Eberhardt, K., Thorbjorn Jensen, L. Horslev-Petersen, K., Petterson, H., Lorenzen, I. Serum aminoterminal type III procollagen peptide in early rheumatoid arthritis: Relation to disease activity and progression of joint damage. Clin Exp Rheum 1990, 8, 335–340.

    CAS  Google Scholar 

  9. Arnett, F.C., Edworthy, S.M., Bloch, D.A., McShane, D.J., Fries, J.F., Cooper, N.S., Healey, L.A., Kaplan, S.R., Liang, M.H., Luthra, H.S., Medsger, T.A., Mitchell, D.M., Neustadt, D.H., Pinals, R.S., Schaller, J.G., Sharp, J.T., Wilder, R.L., Hunder, G.G. The American Rheumatism Association 1988. Criteria for the Classification of Rheumatoid Arthritis. Arthritis Rheum 1988, 31, 315–324.

    Article  CAS  PubMed  Google Scholar 

  10. Rohde, H., Vargas, L., Hahn, E., Kalbfleisch, H., Bruguera, M. Timpl, R. Radioimmunoassay for type III procollagen peptide and its application to human liver disease. Eur J Clin Invest 1979, 9, 451–459.

    Article  CAS  PubMed  Google Scholar 

  11. Thompson, P.W., Silman, A.J., Kirwan, J.R., Currey, H.L.F. Articular indices of joint inflammation in rheumatoid arthritis: Correlation with the acute-phase response. Arthritis Rheum 1987, 30, 618–623.

    Article  CAS  PubMed  Google Scholar 

  12. Duthie, J.J.R., Brown, P.E., Knox, J.D.E., Thomson, M. Course and prognosis in rheumatoid arthritis. Ann Rheum Dis 1957, 16, 411–423.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Fleming, A., Crown, J.M., Corbett, M. Prognosis value of early features in rheumatoid disease. Br Med J 1976, i, 1243–1245.

    Article  Google Scholar 

  14. Cats, A., Hazevoet, H.M., Significance of positive tests for rheumatoid factor in the prognosis of rheumatoid arthritis. Ann Rheum Dis 1970, 29, 254–259.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Teitsson, I., Withrington, R., Seifert, M., Valdimarsson, H. Prospective study of early rheumatoid arthritis: Prognostic value of IgA rheumatoid factor. Ann Rheum Dis 1984, 43, 673–678.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Flemming, A., Mc Guigan, L., Corbett, M. Autoantibody profile of early rheumatoid disease. J Rheumatol 1984, 11, 563–564.

    Google Scholar 

  17. Horslev-Petersen, K., Bentsen, K.D., Halberg, P., Junker, P., Kivirikko, K.I., Majaamaa, K., Bisteli, J., Lorenzen, I. Connective tissue metabolites in serum as markers of disease activity in patients with rheumatoid arthritis. Clin Exp Rheum 1988, 6, 129–134.

    CAS  Google Scholar 

  18. Horslev-Petersen, K., Bentsen, K.D., Engstrom-Laurent, A., Junker P., Halberg, P., Lorenzen, I. Serum aminoterminal type III procollagen peptide and serum hyaluronan in rheumatoid arthritis: relation to clinical and serological parameters of inflammation during 8 and 24 months'treatment with levamisole, penicillamine, or azathiprine. Ann Rheum Dis 1988, 47, 116–126.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Horslev-Petersen, K., Saxne, T., Haar, D., Thomsen, B.S., Bentsen, K.D., Junker, P., Lorenzen, I. The aminoterminal-type-III procollagen peptide and proteoglycans in serum and synovial fluid of patients with rheumatoid arthritis or reactive arthritis. Rheum Int 1988, 8, 1–9.

    Article  CAS  Google Scholar 

  20. Fleischmajer, R., Olsen B.R., Timpl, R., Perlish, J.S., Lovelace, O. Collagen fibril formation during embryogenesis. Proc Natl Acad Sci USA 1983, 80, 3354–3358.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Pullar, T., Capell, H.A. A rheumatological dilemma: Is it possible to modify the course of rheumatoid arthritis? Can we answer the question. Ann Rheum Dis 1985, 44, 134–140.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service de Rhumatologie, Centre Hospitalier Lyon Sud, 69310, Pierre Benite, France

    J. G. Tebib MD, P. Viguier, E. Noel, F. Colson & M. Bouvier

  2. Centre de Medecine Nucleaire, Centre Hospitalier Lyon Sud, 69310, Pierre Benite, France

    Y. Barbier

Authors
  1. J. G. Tebib MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Viguier
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Noel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F. Colson
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Y. Barbier
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Bouvier
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tebib, J.G., Viguier, P., Noel, E. et al. Serum N terminal procollagen III fragment: A predictive marker of joint destruction in rheumatoid arthritis?. Clin Rheumatol 11, 502–507 (1992). https://doi.org/10.1007/BF02283106

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02283106

Key words

Search

Navigation